| Severe COVID-19 is marked by a dysregulated myeloid cell compartment J Schulte-Schrepping, N Reusch, D Paclik, K Baßler, S Schlickeiser, ... Cell 182 (6), 1419-1440. e23, 2020 | 1414 | 2020 |
| SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis D Wendisch, O Dietrich, T Mari, S von Stillfried, IL Ibarra, M Mittermaier, ... Cell 184 (26), 6243-6261. e27, 2021 | 407 | 2021 |
| Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with multiple myeloma MC Da Vià, O Dietrich, M Truger, P Arampatzi, J Duell, A Heidemeier, ... Nature medicine 27 (4), 616-619, 2021 | 247 | 2021 |
| Opposing Wnt signals regulate cervical squamocolumnar homeostasis and emergence of metaplasia C Chumduri, RK Gurumurthy, H Berger, O Dietrich, N Kumar, S Koster, ... Nature cell biology 23 (2), 184-197, 2021 | 90 | 2021 |
| Dynamics of monocyte-derived macrophage diversity in experimental myocardial infarction G Rizzo, J Gropper, M Piollet, E Vafadarnejad, A Rizakou, SR Bandi, ... Cardiovascular research 119 (3), 772-785, 2023 | 78 | 2023 |
| Suppressive myeloid cells are a hallmark of severe COVID-19 J Schulte-Schrepping, N Reusch, D Paclik, K Baßler, S Schlickeiser, ... MedRxiv, 2020.06. 03.20119818, 2020 | 29 | 2020 |
| Sequential antigen loss and branching evolution in lymphoma after CD19-and CD20-targeted T-cell–redirecting therapy J Duell, AM Leipold, S Appenzeller, V Fuhr, H Rauert-Wunderlich, ... Blood 143 (8), 685-696, 2024 | 24 | 2024 |
| Landscape and age dynamics of immune cells in the Egyptian rousette bat V Friedrichs, C Toussaint, A Schäfer, M Rissmann, O Dietrich, ... Cell Reports 40 (10), 2022 | 23 | 2022 |
| Th17. 1 cell driven sarcoidosis-like inflammation after anti-BCMA CAR T cells in multiple myeloma AM Leipold, RA Werner, J Düll, P Jung, M John, E Stanojkovska, X Zhou, ... Leukemia 37 (3), 650-658, 2023 | 21 | 2023 |
| Dysregulated immunometabolism is associated with the generation of myeloid-derived suppressor cells in staphylococcus aureus chronic infection O Dietrich, A Heinz, O Goldmann, R Geffers, A Beineke, K Hiller, ... Journal of innate immunity 14 (3), 257-274, 2022 | 15 | 2022 |
| The life-saving benefit of dexamethasone in severe COVID-19 is linked to a reversal of monocyte dysregulation R Knoll, ET Helbig, K Dahm, O Bolaji, F Hamm, O Dietrich, M van Uelft, ... Cell 187 (16), 4318-4335. e20, 2024 | 7 | 2024 |
| A primary cell-based in vitro model of the human small intestine reveals host olfactomedin 4 induction in response to Salmonella Typhimurium infection T Däullary, F Imdahl, O Dietrich, L Hepp, T Krammer, C Fey, W Neuhaus, ... Gut Microbes 15 (1), 2186109, 2023 | 6 | 2023 |
| Time-resolved scRNA-seq tracks the adaptation of a sensitive MCL cell line to ibrutinib treatment V Fuhr, E Vafadarnejad, O Dietrich, P Arampatzi, A Riedel, AE Saliba, ... International Journal of Molecular Sciences 22 (5), 2276, 2021 | 6 | 2021 |
| Infection immunology DL Yang, SY Ye Wuhan: The Science and Technology press of Hubei, 284-295, 1998 | 3 | 1998 |
| Integrating single-cell multi-omics to decipher host-pathogen interactions O Dietrich PQDT-Global, 2024 | 1 | 2024 |
| SARS-CoV-2 induces fibrosis-associated macrophage signatures and triggers pulmonary fibrosis DC Wendisch, O Dietrich, T Mari, S Von Stillfried, M Mittermeier, P Boor, ... ERJ Open Research 9 (suppl 10), 2023 | 1 | 2023 |
| Pseudoprogression and Sarcoidosis-like Phenomena after CART-Cells and Bispecific Antibodies in Multiple Myeloma A Leipold, R Werner, J Duell, P Jung, M John, E Stanojkovska, X Zhou, ... Blood 140 (Supplement 1), 10020-10021, 2022 | 1 | 2022 |
| Sequential Antigen-loss and Branching Evolution in Lymphoma after Anti-CD19 and Anti-CD20 Targeted T Cell Redirecting Immunotherapy L Rasche, J Duell, A Leipold, S Appenzeller, V Fuhr, H Rauert-Wunderlich, ... | | 2023 |
| Eine Einzelzell-RNA-Sequenzierung identifiziert Metabolismus und CD52 als neue Angriffspunkte in Ibrutinib-persistenten Mantelzelllymphomzellen V Fuhr, E Vafadarnejad, O Dietrich, P Arampatzi, A Riedel, AE Saliba, ... Die Pathologie 43 (Suppl 1), 31-35, 2022 | | 2022 |
| scRNA-sequencing uncovers metabolism and CD52 as new targets in ibrutinib-surviving mantle cell lymphoma cells V Fuhr, E Vafadarnejad, O Dietrich, P Arampatzi, A Riedel, AE Saliba, ... Pathologie (Heidelberg, Germany), 2022 | | 2022 |